Niger vs Senegal: Access to anti-retroviral drugs, male
Niger
56.0%
in 2024
Senegal
56.0%
in 2024
Niger rank
110th
Senegal rank
110th
Access to anti-retroviral drugs, male over time
- Niger
- Senegal
How they compare
Niger currently reports 56.0% against 56.0% in Senegal, a difference of 0.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Senegal ahead.
Niger ranks 110th and Senegal ranks 110th of 141 countries.
Across the 3 decades both report, Niger averaged higher in 2 and Senegal in 1.
Head to head by decade
| Decade | Niger | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.4% | 4.0% | 0.6% | Senegal |
| 2010s | 32.7% | 30.8% | 1.9% | Niger |
| 2020s | 56.0% | 53.4% | 2.6% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Niger or Senegal?
- Niger, at 56.0% against 56.0% in Senegal as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Niger and Senegal?
- 0.0%, with Niger ahead.
- How many years of comparable data are there for Niger and Senegal?
- 25 years are reported by both, from 2000 to 2024.
- How do Niger and Senegal rank globally for access to anti-retroviral drugs, male?
- Niger ranks 110th and Senegal ranks 110th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.